Your browser doesn't support javascript.
loading
Screening for Speech and Language Delay and Disorders in Children: US Preventive Services Task Force Recommendation Statement.
Barry, Michael J; Nicholson, Wanda K; Silverstein, Michael; Chelmow, David; Coker, Tumaini Rucker; Davis, Esa M; Donahue, Katrina E; Jaén, Carlos Roberto; Li, Li; Mangione, Carol M; Ogedegbe, Gbenga; Rao, Goutham; Ruiz, John M; Stevermer, James; Tsevat, Joel; Underwood, Sandra Millon; Wong, John B.
Affiliation
  • Barry MJ; Harvard Medical School, Boston, Massachusetts.
  • Nicholson WK; George Washington University, Washington, DC.
  • Silverstein M; Brown University, Providence, Rhode Island.
  • Chelmow D; Virginia Commonwealth University, Richmond.
  • Coker TR; University of Washington, Seattle.
  • Davis EM; University of Maryland School of Medicine, Baltimore.
  • Donahue KE; University of North Carolina at Chapel Hill.
  • Jaén CR; University of Texas Health Science Center, San Antonio.
  • Li L; University of Virginia, Charlottesville.
  • Mangione CM; University of California, Los Angeles.
  • Ogedegbe G; New York University, New York, New York.
  • Rao G; Case Western Reserve University, Cleveland, Ohio.
  • Ruiz JM; University of Arizona, Tucson.
  • Stevermer J; University of Missouri, Columbia.
  • Tsevat J; University of Texas Health Science Center, San Antonio.
  • Underwood SM; University of Wisconsin, Milwaukee.
  • Wong JB; Tufts University School of Medicine, Boston, Massachusetts.
JAMA ; 331(4): 329-334, 2024 01 23.
Article de En | MEDLINE | ID: mdl-38261037
ABSTRACT
Importance Speech and language delays and disorders can pose significant problems for children and their families. Evidence suggests that school-aged children with speech or language delays may be at increased risk of learning and literacy disabilities, including difficulties with reading and writing.

Objective:

The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate benefits and harms of screening for speech and language delay and disorders in children 5 years or younger. Population Asymptomatic children 5 years or younger whose parents or clinicians do not have specific concerns about their speech, language, hearing, or development. Evidence Assessment The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for speech and language delay and disorders in children who do not present with signs or symptoms or parent/caregiver concerns. Recommendation The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for speech and language delay and disorders in children 5 years or younger without signs or symptoms. (I statement).
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Dépistage de masse / Troubles du développement du langage Type d'étude: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies / Systematic_reviews Limites: Child / Child, preschool / Humans Langue: En Journal: JAMA Année: 2024 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Dépistage de masse / Troubles du développement du langage Type d'étude: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies / Systematic_reviews Limites: Child / Child, preschool / Humans Langue: En Journal: JAMA Année: 2024 Type de document: Article Pays de publication: États-Unis d'Amérique